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Depiction of Viable Tumor in
Hepatocellular Carcinoma Treated with
Transarterial Chemoembolization:
Multiphasic Helical CT with Review of
the Previous Serial CT Images
he utility of multiphasic (biphasic or triphasic) helical CT as a first-line
diagnostic modality for the detection of hepatocellular carcinoma has
been evaluated (1 3). This modality has also been used to evaluate the
therapeutic efficacy and the possibility of residual viable tumor or recurrent tumor
after patients were treated with transarterial chemoembolization for hepatocellular
carcinoma (4).
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Objective: The purpose of our study was to assess whether a review of multi-
phasic helical CT combined with the previous serial CT images could be helpful
to depict a viable tumor in hepatocellular carcinoma treated with transarterial
chemoembolization.
Materials and Methods: Twenty-four consecutive patients with 35 hepatocellu-
lar carcinomas underwent transarterial chemoembolization followed by hepatic
resection. First, three radiologists independently analyzed the last CT images
taken before resection for the presence of viable tumor. A second analysis was
then performed using the last CT combined with the previous serial CT images.
The CT analyses were then compared with the pathologic results. The added
value of the review of the previous serial CT images was evaluated by performing
a receiver operating characteristic analysis. The sensitivity, specificity and diag-
nostic accuracy for the depiction of viable tumor were also assessed, and the
characteristics of the false-negative lesions were pathologically evaluated.
Results: The mean diagnostic accuracies (Az values) for the depiction of viable
tumor with using the last CT alone and with the review of the previous serial CT
images for all observers were 0.885 and 0.901, respectively, which were not sig-
nificantly difference (p > 0.05). However, the additional review of the previous ser-
ial CT images allowed the observers to render a correct diagnosis for three
lesions that had been incorrectly diagnosed with the review of last CT alone. The
sensitivity, specificity and diagnostic accuracy of the last CT along with the review
of the previous serial CT images were 78%, 97% and 84%, respectively. All of the
16 false-negative lesions diagnosed by each observer showed 90% or greater
necrosis on the pathologic examination.
Conclusion: For the depiction of viable tumor in hepatocellular carcinoma
treated with transarterial chemoembolization, although the difference in the diag-
nostic accuracies was not statistically significant, a review of the multiphasic heli-
cal CT combined with the previous serial CT images could help reach a correct
diagnosis for those lesions incorrectly diagnosed with the review of the last CT
alone.It is sometimes difficult to detect any remaining viable
tumor and tumor recurrence because various lesions and
phenomena in the liver show suspicious high attenuation
within or around the iodized oil-containing tumor on the
hepatic arterial phase, and this can mimic tumor enhance-
ment (3, 4). According to a recent study (4), the addition of
unenhanced CT images could increase the diagnostic
confidence for the assessment of viable tumor, compared
with using just the biphasic enhanced CT images, in
patients treated with transarterial chemoembolization for
hepatocellular carcinoma.
In the cases where the findings on the last CT, including
the unenhanced images, are inconclusive, we questioned
the value of reviewing the previous serial CT images.
Therefore, we retrospectively evaluated whether a review
of the multiphasic helical CT combined with previous serial
CT images could be helpful for depicting a viable tumor in
hepatocellular carcinoma treated with transarterial
chemoembolization.
MATERIALS AND METHODS
Patient Selection
From October 1996 to November 2002, 30 consecutive
patients with hepatocellular carcinomas underwent transar-
terial chemoembolization followed by hepatic resection at
our institution. Of these patients, we included the patients
who met the two following criteria: (a) two or more four-
phase (i.e., hepatic arterial, portal venous, and delayed
phase, and unenhanced image) helical CTs were taken
after the first transarterial chemoembolization, and (b)
hepatic resection was done within one month of the last
follow-up CT. Finally, 24 patents with 35 hepatocellular
carcinomas were included in this study. Eighteen patients
had one tumor, four patients had two tumors, one patient
had three tumors and one patient had six tumors. They
underwent lobectomy (n = 22), segmentectomy (n = 1) or
liver transplantation (n = 1) after transarterial chemoem-
bolization. Of these, 20 patients could undergo hepatic
resection because they had recovered enough hepatic
function to endure hepatic surgery, as compared to the
time when they had undergone the initial transarterial
chemoembolization. There were 21 men and three
women, and their ages ranged from 38 to 73 years (mean
age; 54 years). This study was approved by the institu-
tional review board of our hospital.
All the patents in the study had liver cirrhosis as a result
of either hepatitis B (n = 23), or hepatitis C (n = 1).
Twenty-six hepatocellular carcinomas were diagnosed by
the pathologic results for those patients that demonstrated
viable tumor in the resected specimens. Of the nine totally
necrotic tumors, the diagnosis of three hepatocellular
carcinomas was established based on the results of percuta-
neous needle biopsy. The remaining six hepatocellular
carcinomas showed the characteristic laboratory findings
(e.g., elevated  -fetoprotein levels and viral markers) in
combination with the characteristic radiological findings on
the follow-up CT images. The mean diameter of the
hepatocellular carcinomas was 3.7 cm (range; 0.5 12 cm). 
Seventeen patients underwent multiple treatments of
transarterial chemoembolization (range; 2 5 treatments,
mean; 2.9 treatments). The remaining seven patients
underwent it once. The mean interval between the transar-
terial chemoembolization and the follow-up CT was 20
days (range; 3 23 days), and the mean interval between
the last CT and surgery was 14 days (range; 1 30 days).
Multiphasic Helical CT
The CT scans were performed with a helical scanner
(HiSpeed Advantage; GE Medical Systems, Milwaukee,
WI, USA). The scanning parameters were 120 kVp, 180
mAs, 7 mm section collimation and a 7 mm/sec table speed
during a single breath-hold helical acquisition of 25 30
seconds, depending upon the liver size. The images were
obtained in a craniocaudal direction and they were
reconstructed every 7 mm to provide contiguous or
overlapping sections for the unenhanced and enhanced
images. After the acquisition of the unenhanced images,
the hepatic arterial phase, the portal venous phase and the
delayed phase images were obtained with delays of 30, 60
and 180 seconds, respectively, after the start of injecting
120 mL of nonionic iodinated contrast material (Iopamiro
300, Bracco, Milano, Italy and Ultravist 300, Schering,
Berlin, Germany) through the antecubital vein at a rate of
3 mL/sec.
Transarterial Chemoembolization Techniques
Transarterial chemoembolization was performed with a
mixture of iodized oil (Lipiodol; Guerbet, Aulnay-sous-
Bois, France) and doxorubicin hydrochloride (Adriamycin;
Kyowa Hakko Kogyo, Tokyo, Japan) in all the patients.
We used 3 mg of doxorubicin hydrochloride and 1 cc of
iodized oil per 1-cm diameter of the tumor. For particle
embolization, we also used Gelfoam powder (Upjohn,
Kalamazoo, MI, USA) if a patient had neither Child class C
cirrhosis nor thrombosis in the major portal vein. The
injection was continued until stasis was identified in the
feeding artery. Infusion and embolization was performed
with the catheter in a lobar or segmental artery.
Pathologic Analysis
All surgical specimens were reviewed by an experienced
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at 5-mm intervals and the tumor necrosis was estimated as
a percentage. The percentage of tumor necrosis was
determined after investigating all the sections. The
pathologic findings that were used as the standards of
reference revealed that nine of the 35 hepatocellular
carcinomas were totally necrotic.
Image Analysis
The CT images were retrospectively and independently
reviewed by three radiologists. One observer had 24 years
experience at abdominal imaging and other two observers
had five years experience each. The observers were
informed of the patients’ histories in as much as they knew
that all the patients had undergone transarterial chemoem-
bolization for hepatocellular carcinoma, but the observers
were blinded to the pathologic findings concerning the
presence of viable tumor in each patient. First, the
observers reviewed the last four-phase CT taken before
liver resection. Second, the observers repeated the review
two weeks after the first interpretation with using the last
CT combined with the previous serial CT images. The
observers were obliged to review the second-to-the-last
CT. Further review of the other previous CT examinations
was determined by the respective decision of the observers
for each case.
All images were evaluated using a 2,000 2,000 Picture
Archiving and Communication Systems (PACS; GE
Medical Systems Integrated Imaging Solutions, Mt
Prospect, IL, USA) monitor. The images were initially
evaluated using two window settings (window level; 60
HU, window width; 350 HU, and window level; 110 HU,
window width; 200 HU), and then the window settings
were adjusted as needed. Images were interpreted for the
presence, number, size and site of the viable tumors.
The image review was conducted on a tumor-by-tumor
basis. Each observer also recorded his or her degree of
confidence as to whether a lesion seen on an image
represented a viable tumor. The attenuation of each lesion
in relation to that of the liver (i.e., hypoattenuation,
hyperattenuation, isoattenuation or mixed attenuation)
was subjectively assessed. The diagnostic confidence for
each lesion was scored using a five-point scale (1, not
viable tumor; 2, probably not viable tumor; 3, possibly
viable tumor; 4, probably viable tumor; 5, definitely viable
tumor) at each interpretation session.
For the objectivity and reproducibility of the image
analysis performed in this study, the important criteria for
a viable tumor and for the noncancerous lesions were
determined. We regarded the following lesions as viable
areas of tumors on the last CT images: (a) a hyperattenuat-
ing or isoattenuating lesion seen during the hepatic arterial
phase and as a hypoattenuating lesion seen during the
portal venous phase or the delayed phase, (b) an area of
mixed attenuation seen on the hepatic arterial phase
images that showed a hypoattenuating portion either on
the portal venous phase or the delayed phase, and (c) a
nodule that was seen as being isoattenuation on the hepatic
arterial phase, the portal venous phase or the delayed
phase images, but it was seen as hypoattenuation on the
unenhanced images (4). A lesion that showed wedge-
shaped hyperattenuation during the hepatic arterial phase
and that appeared as isoattenuation on the portal venous
phase, on the delayed phase images and on the
unenhanced images was considered to be a noncancerous
lesion.
When the last CT along with the previous serial CT
images was reviewed, a lesion that showed a newly
presenting defect within an iodized oil-containing nodule
was regarded as a viable portion of tumor. A small peritu-
moral area with suspicious enhancement on the hepatic
arterial phase of the last CT, which showed an iodized oil-
containing liver parenchyma on the previous serial CT
images, was considered as an arterioportal shunt and not as
a viable tumor. Also, a long-standing hypoattenuating area
(longer than one year) that did not change after contrast
enhancement within a nodule of hepatocellular carcinoma
was not considered viable tumor.
A radiologist (the study coordinator) and a pathologist
reviewed the pathologic findings and their correlation with
the multiphasic CT findings. They evaluated the location
(upper or lower, right or left, and anterior or posterior) and
the size of the viable portions within the tumors on both
the CT and the pathologic examinations.
Statistical Analysis
A binominal receiver operating characteristic (ROC)
curve was calculated for each observer’s confidence rating
data with using maximum-likelihood estimation. We
evaluated the diagnostic accuracy of the last CT alone and
the last CT combined with the previous serial CT images
by calculating the area under each observer-specific
binomial ROC curve (denoted as the Az index) (5). The
lesions that were assigned a score of three to five were
considered as diagnosed viable tumors. The sensitivity and
specificity were calculated for each observer and for each
different review of the CTs, and the statistical analysis of
their differences was assessed using the McNemar test
(SPSS, version 10.0; SPSS, Chicago, IL, USA). The false
negative rates for the detection of viable tumors were also
calculated for the review of the last CT alone and for the
review of the last CT along with the previous serial CT
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statistically significant.  statistics were used to assess the
interobserver agreement for the presence of a viable
portion of tumor with the review of the last CT alone and
with the review of the last CT combined with the previous
serial CT images. The degree of agreement was catego-
rized as follows:  values of 0.00 0.20 were considered to
indicate poor agreement,  values of 0.21 0.40 were
considered to indicate fair agreement,  values of 0.41
0.60 were considered to indicate moderate agreement, 
values of 0.61 0.80 were considered to indicate good
agreement and  values of 0.81 1.00 were considered to
indicate excellent agreement (5). 
RESULTS
During the two analyses of the CT images, each observer
detected all 35 hepatocellular carcinomas that were
pathologically demonstrated in the resection specimens.
The mean diagnostic accuracies (Az values) for the
depiction of viable tumor with the last CT alone and with
the review of previous serial CT images for all the
observers were 0.885 and 0.901, respectively (p > 0.05)
(Table 1). The sensitivity, specificity and diagnostic
accuracy of the last CT alone were 72%, 91% and 78%,
respectively, and the corresponding values for the review
of the last CT combined with the previous serial CT images
were 78%, 97% and 84%, respectively (Table 2), and the
differences were not statistically significant. Although these
differences in the diagnostic accuracies were not statisti-
cally significant, the review of the previous images enabled
the observers to render a correct diagnosis for three (9%)
tumors. Two of these three tumors showed as being
slightly hyperattenuating focal areas adjacent to the
iodized oil-containing tumors on the hepatic arterial phase
images of the last CT, and these two tumors appeared as
isoattenuating areas on the unenhanced images. The
second to the last CT showed that these areas appeared as
parenchymal uptake around the iodized oil-containing
tumors (Fig. 1), and the two observers changed their
confidence levels to probably not viable tumor. The
tumors were totally necrotic on the pathologic examina-
Jang et al.
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Table 2. The Sensitivity and Specificity for Detection of the Viable Tumor on the Review of the Last CT alone and on the
Review of the Last CT along with the Previous CT
Image Analysis Observer 1 Observer 2 Observer 3 Total
Sensitivity* (24 viable hepatocellular carcinomas)
Last CT alone 18 (75) 17 (71) 17 (71) 52 (72)
Last CT with previous CT 20 (83) 18 (75) 18 (75) 56 (78)
Specificity  (11 total necrotic hepatocellular carcinomas)
Last CT alone 10 (91) 10 (91) 10 (91) 30 (91)
Last CT with previous CT 11 (100) 10 (91) 11 (100) 32 (97)
Diagnostic accuracy (35 hepatocellular carcinomas)
Last CT alone 25 (80) 27 (77) 27 (77) 82 (78)
Last CT with previous CT 31(89) 28(80) 29 (83) 88 (84)
Note. Data are the numbers of lesion assigned a score of 3-5 for the sensitivity among the 24 viable  hepatocellular carcinomas that were confirmed on
the pathologic findings, and those lesions were assigned a score of 1 or 2 for the specificity among the 11 total necrotic hepatocellular carcinomas. 
The numbers in parentheses indicate the sensitivity, specificity and accuracy expressed as percentages.
* For each observer and the composite date, the differences between the sensitivities of the review of the last CT alone and the review of the last CT along
with the previous CT were not statistically significant (p > 0.05, McNemar test).
For each observer and the composite data, the differences between the specificities for the review of the last CT alone and the last CT along with the
previous CT were not statistically significant (p > 0.05, McNemar test).
Table 1. The Individual and Mean Areas Under the Curve (Az) with the p values for the Review of the Last CT alone and for the
Review of the Last CT along with the Previous CT in the Detection of Viable Tumor in Hepatocellular Carcinoma
Treated with Transarterial Chemoembolization
Image Analysis Observer 1 Observer 2 Observer 3 Mean
Az value of the last CT alone 0.922 0.045 0.860 0.062 0.860 0.062 0.885 0.032
Az value of the last CT with previous CT 0.964 0.030 0.877 0.058 0.875 0.058 0.901 0.029
Difference in the Az values 0.042 0.029 0.017 0.020 0.015 0.031 0.016 0.016
p value 0.150 0.385 0.624 0.345
Note. Data are means 1 standard deviation.tion. The one remaining tumor showed as an interval
developed defect within the iodized oil-containing nodule
that was not significantly enhanced on the last CT. On the
basis of this feature, the two observers changed their
confidence level to probably viable tumor. The pathology
revealed a 70% necrotic hepatocellular carcinoma.
After reviewing of the last CT and the previous serial CT
images, all three observers assessed the 10 compact
iodized oil-containing tumors as being non-viable. Of
these, eight were totally necrotic tumors that were
confirmed on the pathologic findings. The two remaining
tumors were 95% and 90% necrotic tumor, respectively.
Thus, the compact iodized oil-containing tumors showed a
mean necrosis rate of 98.5%. 
All of the 16 false-negative lesions that were diagnosed
by each observer after reviewing the last CT combined with
the previous serial CT images showed 90% or greater
necrosis on the pathologic examination (Table 3).
Particularly, four tumors of these lesions were diagnosed as
negative lesions simultaneously by all the observers with
both the review of the last CT alone and the review of the
last CT with the previous serial CT images. All of these four
tumors were 1.5 cm in diameter or smaller. Two of these
were compact iodized oil-containing tumors (Fig. 2). The
Effect of Previous Serial CT Review on Viable Tumor Depiction of Hepatocellular Carcinoma after Transarterial Chemoembolization
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AB
Fig. 1. A 56-year-old man who had undergone one time preoperative treatment with transarterial chemoembolization and right
lobectomy. The pathologic examination revealed totally necrotic tumor.
A, B. On the last contrast-enhanced CT, the lesion that is a focal slightly hyperattenuating area (arrow) adjacent to the iodized oil-
containing nodule on the hepatic arterial phase CT image (A) appears as an isoattenuating area (arrow) at the corresponding region on
the unenhanced CT image (B). This lesion was interpreted as a viable tumor by all the observers after reviewing the last CT alone.
C, D. On the second to the last CT taken three weeks after the transarterial chemoembolization, the hepatic arterial phase (C) and
unenhanced CT images (D) show that the hyperattenuating lesion seen in Figure A appears to be iodized oil-containing hepatic
parenchyma (arrow). After reviewing the previous serial CT images, the two observers interpreted this hyperattenuating lesion on the last
hepatic arterial phase CT as an arteriovenous shunt, and they changed the confidence level to probably not viable tumor.
CDJang et al.
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Fig. 2. A 52-year-old man who had undergone three transarterial chemoembolization treatments and right hepatic lobectomy. 
A, B. The unenhanced CT images show two compact iodized oil-containing nodules at S8 (arrow) and S6 (arrowhead) of the liver.
C-F. These contrast-enhanced CT scans obtained during the arterial phase (C, D) and the delayed phase (E, F) show neither enhancing
portions nor defects within the iodized oil-containing nodules at S8 (arrow) and S6 (arrowhead). The two tumors were interpreted as non-
viable tumors by all the observers. The pathologic examination revealed that the S6 tumor was 90% necrotic and that the S8 tumor was
totally necrotic.
EFremaining two showed no definite enhancement in the
iodized oil defect portion on the hepatic arterial phase CT.
The interobserver agreement ( statistic) for the presence
of a viable tumor was 0.828 to 0.943 for the review of the
last CT alone and 0.826 to 0.885 for the additional review
of the previous serial CT images (Table 4). The interob-
server agreement for the review of the last CT with or
without the previous serial CT images was considered
excellent. 
DISCUSSION
The criteria suggested by the World Health Organization
and that is used for evaluating the effect of chemotherapy
on cancer cannot be applied to the evaluation of transarte-
rial chemoembolization therapy because any tumor
reduction can seldom be recognized before one month
after the treatment (6). Thus, other criteria have been
evaluated to determine the efficacy of transarterial
chemoembolization treatment for hepatocellular
carcinoma by using iodized oil retention in a tumor and the
enhancement on CT (7, 8). After the initial remission
following transarterial chemoembolization, Lee et al. (9)
suggested that the overall cumulative recurrence rate of
hepatocellular carcinoma was 23% after one year, 55%
after two years and 67% after three years, and 45% of the
recurrences occurred adjacent to a primary site that was
considered controlled by the transarterial chemoemboliza-
tion. Hence, periodic CT follow-up or angiography might
be recommended even though there may be the appear-
ance of complete remission for hepatocellular carcinoma.
With the advent of helical CT and with the other rapid
technical advances, multiphasic helical CT has recently
become a more useful imaging modality for the detection
and characterization of liver lesions, for the follow-up after
local treatment or surgical excision, and for the assessment
of the hemodynamic changes in the liver. However, to the
best of our knowledge, there has been no previous study
that has compared the preoperative CT and the review of
the previous serial CT images with the resected specimens
for the evaluation of the viable portion of hepatocellular
carcinoma treated with transarterial chemoembolization.
In the past, some investigators have reported on the
diagnostic efficacy of the hepatic arterial phase CT and the
portal venous phase CT for the detection of hypervascular
tumors, and especially hepatocellular carcinoma (10, 11).
Lim et al. (1) have suggested that the delayed phase is
important for the detection of small hepatocellular carcino-
mas that are less than 2 cm, for confirming or increasing
the confidence level for the detection of equivocal nodules
on the arterial or portal venous phase images (because
those nodules are usually more conspicuous on the delayed
phase than on the portal venous phase imaging), and for
the differentiation of arterioportal shunting from the true
hepatocellular carcinoma. In our study, this concept was
used to depict a viable tumor among the arterioportal
shunt areas.
For the hepatocellular carcinoma treated with transarter-
ial chemoembolization, Takayasu et al. (8) have suggested
that the iodized oil deposition in a tumor could be consid-
ered as necrosis. Choi et al. (7) have also proposed that the
complete retention of iodized oil in a tumor and the
surrounding liver demonstrated the best therapeutic
effects. We adopted this principal criterion for the iodized
oil retention in our study.
Kim et al. (4) have recently pointed out that unenhanced
images could be of additional diagnostic value to supple-
ment the enhanced biphasic helical CT images for the
patients treated with transarterial chemoembolization for
hepatocellular carcinoma by facilitating the differentiation
of the true lesions from the hyperattenuating pseudolesions
Effect of Previous Serial CT Review on Viable Tumor Depiction of Hepatocellular Carcinoma after Transarterial Chemoembolization
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Table 3. False - Negative Results for the Viable Tumor in Hepatocellular Carcinoma after Transarterial Chemoembolization
Necrotic Amount of 
Observer 1 Observer 2 Observer 3
Hepatocellular Carcinoma
Last CT Last CT with Last CT Last CT with   Last CT Last CT with 
Alone Previous CT Alone Previous CT Alone Previous CT
< 90% 0 0 1 0 1 0
90% 6 4 7 6 7 6
Note. Data show the number of viable tumors in the hepatocellular carcinomas that were missed by the observers.
Table 4. Agreement among the Observers Regarding the
Presence of Viable Tumor in Hepatocellular
Carcinoma after Transarterial Chemoembolization
Image Analysis Observer 1  Observer 2  Observer 1
vs. 2 vs. 3 vs. 3
Last CT alone 0.943 0.886 0.828
Last CT with previous CT 0.826 0.828 0.885
Note. Data show  values that indicate the degree of agreement
between all the pairs of observers regarding the presence or absence of
viable tumor in hepatocellular carcinoma after transarterial
chemoembolization.
value > 0.8, excellent agreement that simulate viable tumor. Further, they stated that these
unenhanced images can also aid in the detection of any
isoattenuation lesion on the hepatic arterial phase and the
portal venous phase because of the hypoattenuation on the
unenhanced images. We also evaluated the unenhanced
images, and we used the criteria suggested by Kim et al.
(4). 
In addition to the criteria in the previous studies (1, 4, 7,
10, 11), we considered the long-standing hypoattenuating
areas within an iodized nodule on the enhanced images of
the serial CT images as necrotic lesion despites a lack of
iodized oil. On the other hand, a lesion that showed an
interval developed defect within an iodized nodule was
considered as a viable portion of tumor.
In our study, although no significant statistical difference
was found between the review of the last CT alone and the
review of the last CT along with the previous serial CT
images, the additional review of the previous serial CT
images allowed the observers to render a correct diagnosis
for three (9%) lesions. We believe that many abdominal
radiologists actually do review some of the previous CT
images when they find an equivocal viable lesion on the
liver CT following transarterial chemoembolization.
According to our results, after the review of the last CT
combined with the previous serial CT images, all the false-
negative lesions showed 90% or greater necrosis on the
pathologic examination. Thus, if a substantial (larger than
10%) viable tumor is present in an iodized nodule, we can
depict it on CT with a thorough review of the previous
serial CT images.
Our study has some limitations. First, as this is a
retrospective study, all the patients of the study group did
not undergo regular follow-up CT and transarterial
chemoembolization because of suspected complications or
because of personal preference. Second, we included a
relatively small number of hepatocellular carcinomas, and
so this might show no significant statistical difference
between the review of the last CT alone and the review of
the last CT along with the previous serial CT images.
Finally, although we thoroughly reviewed the pathologic
specimens alongside the CT images, any perfect area-by-
area histopathologic correlation was actually impossible.
By referring to the location and size of viable tumors
within the tumors, however, we tried to match the CT and
histopathologic findings as closely as possible. In our
results, two of the three tumors that had a correct diagnosis
rendered after the review of previous images appeared as
parenchymal uptake around the iodized oil-containing
tumors on the second to the last CT. The pathology
demonstrated totally necrotic tumors, and this revealed
that the suspicious hyperattenuating focal areas adjacent to
the iodized oil-containing tumors on the hepatic arterial
phase images of the last CT were pseudolesion. For the
third hepatocellular carcinoma with 70% necrosis, we
could not perfectly match the interval developed defect
within the iodized oil-containing nodule and the 30%
viable tumor portion on the pathologic specimen. Also, we
do not know the reason why the two compact iodized oil-
containing tumors seen on CT had viable tumor portions
on the pathology examination.
In conclusion, for depicting the viable tumor in hepato-
cellular carcinoma patients treated with transarterial
chemoembolization, although the difference in the
diagnostic accuracies was not found to be statistically
significant in our study, a review of the multiphasic helical
CT combined with the previous serial CT images can help
render a correct diagnosis for those lesions incorrectly
diagnosed with the review of only the last CT.
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